logo

Acorda Therapeutics Inc. (ACOR)



Trade ACOR now with
  Date
  Headline
3/9/2022 4:11:19 PM Acorda Therapeutics Q4 Loss/share $1.73 Vs. Loss $9.82 Year Ago
1/3/2022 4:10:22 PM Acorda Therapeutics Appoints John Varian To Board Of Directors
9/9/2021 8:09:56 AM Acorda Therapeutics To Reduce Headcount By 15%, Sees $3 Mln Of Pre-tax Charges
6/16/2021 7:05:40 AM Acorda Therapeutics Reports Repayment Of Convertible Senior Notes
2/19/2021 7:05:37 AM Acorda Therapeutics: David Lawrence Is Resigning From Company Effective Mid-March, 2021
2/11/2021 7:24:40 AM Acorda Therapeutics Says Completes Sale Of Its Manufacturing Ops. In Chelsea, Massachusetts To Catalent
1/13/2021 7:11:56 AM Acorda To Sell Its INBRIJAmanufacturing Operations In Chelsea, Massachusetts To Catalent For $80 Mln Cash
10/31/2017 5:17:21 PM Jefferies Is Cutting Acorda Therapeutics Inc. (ACOR) FY18 Rev. Estimate To 337.8 M From 382.1 M
10/31/2017 5:17:08 PM Jefferies Is Lowering Acorda Therapeutics Inc. (ACOR) FY17 Rev. Estimate To 568.2 M From 570.5 M
10/31/2017 5:16:36 PM Jefferies Is Cutting Acorda Therapeutics Inc. (ACOR) FY18 Estimate To -1.59 From -1.27
10/31/2017 5:16:15 PM Jefferies Is Lowering Acorda Therapeutics Inc. (ACOR) FY17 Estimate To -0.17 From 0.56
4/14/2014 10:05:02 AM FBR Capital Markets Is Cutting Acorda Therapeutics Inc. (ACOR) 4Q14 Estimate To 0.27 From 0.28
4/14/2014 10:00:18 AM FBR Capital Markets Is Increasing Acorda Therapeutics Inc. (ACOR) 3Q14 Estimate To 0.28 From 0.26
4/14/2014 9:59:42 AM FBR Capital Markets Is Increasing Acorda Therapeutics Inc. (ACOR) 2Q14 Estimate To 0.28 From 0.25
4/14/2014 9:59:14 AM FBR Capital Markets Is Raising Acorda Therapeutics Inc. (ACOR) 1Q14 Estimate To 0.22 From 0.19
4/14/2014 9:58:45 AM FBR Capital Markets Is Raising Acorda Therapeutics Inc. (ACOR) 2015 Estimate To 1.55 From 1.17
4/14/2014 9:58:15 AM FBR Capital Markets Is Increasing Acorda Therapeutics Inc. (ACOR) 2014 Estimate To 1.05 From 0.99